Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-9-19
|
pubmed:abstractText |
The electrophilic affinity ligand, (+)-3-isothiocyanato-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cycl ohepten-5,10 - imine hydrochloride [(+)-MK801-NCS] was characterized for its ability to acrylate phencyclidine (PCP) and sigma binding sites in vivo. Initial studies, conducted with mouse brain membranes, characterized the binding sites labeled by [3H]1-[1-(2-thienyl)cyclohexyl]piperidine ([3H]TCP). The Kd values of [3H]TCP for PCP site 1 (MK801-sensitive) and PCP site 2 (MK801-insensitive) were 12 nM and 68 nM, with Bmax values of 1442 and 734 fmol/mg protein, respectively. Mice were sacrificed 18-24 hours following intracerebroventricular administration of the acylator. The administration of (+)-MK801-NCS increased [3H]TCP binding to site 2, but not to site 1. Although (+)-MK801-NCS decreased [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d; ccyclohepten-5,10-imine maleate ([3H](+)-MK801) binding to site 1, it had no effect on [3H]TCP binding to site 1. Viewed collectively with other published data, these data support the hypothesis that PCP sites 1 and 2 are distinct binding sites, and that [3H]TCP and [3H](+)-MK801 label different domains of the PCP binding site associated with the NMDA receptor.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1-(1-(2-thienyl)cyclohexyl)piperidin...,
http://linkedlifedata.com/resource/pubmed/chemical/3-isothiocyanato-5-methyl-10,11-dihy...,
http://linkedlifedata.com/resource/pubmed/chemical/Affinity Labels,
http://linkedlifedata.com/resource/pubmed/chemical/Dizocilpine Maleate,
http://linkedlifedata.com/resource/pubmed/chemical/Phencyclidine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Phencyclidine,
http://linkedlifedata.com/resource/pubmed/chemical/Street Drugs
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0364-3190
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8065494-Affinity Labels,
pubmed-meshheading:8065494-Animals,
pubmed-meshheading:8065494-Brain,
pubmed-meshheading:8065494-Cell Membrane,
pubmed-meshheading:8065494-Cerebral Ventricles,
pubmed-meshheading:8065494-Dizocilpine Maleate,
pubmed-meshheading:8065494-Injections, Intraventricular,
pubmed-meshheading:8065494-Male,
pubmed-meshheading:8065494-Mice,
pubmed-meshheading:8065494-Mice, Inbred ICR,
pubmed-meshheading:8065494-Phencyclidine,
pubmed-meshheading:8065494-Receptors, Phencyclidine,
pubmed-meshheading:8065494-Street Drugs
|
pubmed:year |
1994
|
pubmed:articleTitle |
An electrophilic affinity ligand based on (+)-MK801 distinguishes PCP site 1 from PCP site 2.
|
pubmed:affiliation |
Clinical Psychopharmacology Section, NIDA/NIH Addiction Research Center, Baltimore, MD 21224.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|